| | | | | | | | | | | | | | | | | | | | | |
Ownership Document |
Schema Version: X0306 |
Document Type: 4 |
Period of Report: 9/12/22 |
Not Subject to Section 16: 0 |
Issuer: |
| Issuer CIK: 1770787 |
| Issuer Name: 10x Genomics, Inc. |
| Issuer Trading Symbol: TXG |
Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1786720 |
| | Owner Name: Saxonov Serge |
| Reporting Owner Address: |
| | Owner Street 1: C/O 10X GENOMICS, INC. |
| | Owner Street 2: 6230 STONERIDGE MALL ROAD |
| | Owner City: PLEASANTON |
| | Owner State: CA |
| | Owner ZIP Code: 94588 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? Yes |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: Chief Executive Officer |
| | Other Text: |
Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Class A Common Stock |
| | Transaction Date: |
| | | Value: 9/12/22 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: M |
| | | Equity Swap Involved? No |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 11,500 |
| | | Transaction Price Per Share: |
| Value: 1.2 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 977,602 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Non-Derivative Holding: |
| | Security Title: |
| | | Value: Class A Common Stock |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 2,487 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: I |
| | | Nature of Ownership: |
| Value: See footnote |
| Footnote ID: F1 |
| Non-Derivative Holding: |
| | Security Title: |
| | | Value: Class A Common Stock |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 89,960 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: I |
| | | Nature of Ownership: |
| Value: See footnote |
| Footnote ID: F2 |
Derivative Table: |
| Derivative Transaction: |
| | Security Title: |
| | | Value: Stock Option (right to buy) |
| | Conversion or Exercise Price: |
| | | Value: 1.2 |
| | Transaction Date: |
| | | Value: 9/12/22 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: M |
| | | Equity Swap Involved? No |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 11,500 |
| | | Transaction Price Per Share: |
| Value: 0 |
| | | Transaction Acquired-Disposed Code: |
| Value: D |
| | Exercise Date: |
| | | Footnote ID: F3 |
| | Expiration Date: |
| | | Value: 10/18/27 |
| | Underlying Security: |
| | | Underlying Security Title: |
| Value: Class A Common Stock |
| | | Underlying Security Shares: |
| Value: 11,500 |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 41,035 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
Footnotes: |
| Footnote - F1: The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee. |
| Footnote - F2: The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee. |
| Footnote - F3: This option, originally for 300,000 shares, of which 258,965 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
Owner Signature: |
| Signature Name: /s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov |
| Signature Date: 9/14/22 |